,Variant_classification,Gene_classification,Comment,Difficultregion,CNV-SNV,ID,OMIM_Phenotype,Disease,Clinical_synopsis,OMIM_Link,Uniprot,Inheritance,Zygosity,CHR,POS,REF,ALT,Flank,Repeat_flag,FILTER,FORMAT,VAF,Pileup_data,Mutation_type,Gene_name,Entrez_Gene_Id,In_Key_Gene,HGVS_nomenclature,HGMD_transcript,ExonNumber,PolarChange,1000G_ASN_AF,1000G_ALL_AF,ESP6500_AC,ESP6500_AF,gnomAD_exome_ALL,gnomAD_exome_EAS,gnomAD_genome_ALL,gnomAD_genome_EAS,ExAC_EAS_HomoAlt_Count,ExAC_EAS_AC,ExAC_EAS_AF,ExAC_HomoAlt_Count,ExAC_AC,ExAC_AF,In_house_freq,In_house_count,ExAC_Link,ExAC_MisZ,ExAC_Expected,ExAC_observed,ExAC_PLI,PLI_Link,Phylop_Vertebrate_score,Phylop_Mammal_score,SIFT_score,SIFT_prediction,Polyphen2_HDIV_score,Polyphen2_HDIV_pred,Polyphen2_HVAR_score,Polyphen2_HVAR_pred,LRT_score,LRT_prediction,Mutationtatser_score,Mutationtatser_prediction,Gerp++,CADD,Rs_ID,Swiss_prot_function,Swiss_prot_disease_association,Swiss_prot_post_translational_modifications,Swiss_prot_expression,HGMD_mutation_type,HGMD_variant_class,HGMD_disease,HGMD_pubmed_ID,HGMD_indel_type,HGMD_Indel_class,HGMD_indel_disease,HGMD_indel_PMID,HGMD_nearby_alleles,Clinvar,Clinvar_Link,CosmicID,Cosmic_Occurence,Mother_zygosity,Mother_filter,Mother_format,Mother_VAF,Mother_pileup,Father_zygosity,Father_filter,Father_format,Father_VAF,Father_pileup,Recessive,Com_het,De_novo,Other_relatives,Covered,Less_20,GO_BP,GO_CC,GO_MF,KEGG_PATHWAY,PID_PATHWAY,BIOCARTA_PATHWAY,REACTOME_PATHWAY,pheno_rank,intersect_rank,CaseID
156,.,.,OMIM|novel,Name=SegmentalDuplications,.,NFS17007000102,610443,Koolen-De Vries syndrome,"1.$$$mimNumber,610443###prefix,####preferredTitle,KOOLEN-DE VRIES SYNDROME; KDVS###inheritance,Autosomal dominant ###growthWeight,Intrauterine growth retardation ;###growthWeight,Low birth weight (27%) ;###growthWeight,Failure to thrive ###headAndNeckFace,Long face (74%) ;###headAndNeckFace,High, broad forehead (68%) ;###headAndNeckFace,Broad chin (42%) ###headAndNeckEars,Large, prominent ears (59%) ;###headAndNeckEars,Anteverted ears ;###headAndNeckEars,Overfolded helices ###headAndNeckEyes,Hypermetropia (36%) ;###headAndNeckEyes,Pale irides (45%) ;###headAndNeckEyes,Strabismus (45%) ;###headAndNeckEyes,Upward-slanted palpebral fissures (68%) ;###headAndNeckEyes,Blepharophimosis (36%) ;###headAndNeckEyes,Ptosis (50%) ;###headAndNeckEyes,Epicanthal folds (68%) ###headAndNeckNose,Tubular nose (82%) ;###headAndNeckNose,Pear-shaped nose (82%) ;###headAndNeckNose,Bulbous nasal tip (95%) ;###headAndNeckNose,High nasal bridge ###headAndNeckMouth,High, narrow palate (50%) ;###headAndNeckMouth,Cleft lip ;###headAndNeckMouth,Cleft palate ;###headAndNeckMouth,Everted lower lip ;###headAndNeckMouth,Open mouth ###headAndNeckTeeth,Small widely spaced teeth ###cardiovascularHeart,Heart defects (27%) ;###cardiovascularHeart,Atrial septal defect ;###cardiovascularHeart,Ventricular septal defect ;###cardiovascularHeart,Pulmonary valve stenosis ;###cardiovascularHeart,Bicuspid aortic valve ;###cardiovascularHeart,Aortic dilatation (reported in 1 patient) ###chestExternalFeatures,Pectus excavatum (23%) ;###chestExternalFeatures,Widely spaced nipples ###genitourinary,Kidney/urologic anomalies (32%) ###genitourinaryKidneys,Hydronephrosis ;###genitourinaryKidneys,Duplex renal system ###genitourinaryBladder,Vesicoureteric reflux ###skeletal,Hypermobile joints ###skeletalSpine,Scoliosis/kyphosis (36%) ###skeletalPelvis,Hip dislocation (27%) ###skeletalLimbs,Slender lower limbs (41%) ###skeletalHands,Narrow hands (28%) ;###skeletalHands,Long, slender fingers (61%) ;###skeletalHands,Hypoplasia of the hand muscles (29%) ###skeletalFeet,Positional foot deformity (27%) ###skinNailsHairSkin,Dry skin ;###skinNailsHairSkin,Eczema ;###skinNailsHairSkin,Pigmentary abnormalities ;###skinNailsHairSkin,Sacral dimple ###skinNailsHairHair,Abnormal hair pigmentation (55%) ;###skinNailsHairHair,Abnormal hair texture (55%) ###muscleSoftTissue,Hypoplasia of the hand muscles (29%) ###neurologicCentralNervousSystem,Developmental delay (100%) ;###neurologicCentralNervousSystem,Mental retardation, mild to severe ;###neurologicCentralNervousSystem,Poor speech development ;###neurologicCentralNervousSystem,Hypotonia (96%) ;###neurologicCentralNervousSystem,Seizures (50%) ;###neurologicCentralNervousSystem,Ventriculomegaly (38%) ###neurologicBehavioralPsychiatricManifestations,Friendly behavior (89%) ###voice,Nasal speech (50%) ###miscellaneous,All cases are de novo ;###miscellaneous,Estimated prevalence of 1 in 16,000 ;###miscellaneous,Contiguous gene deletion of 17q21.3 involves a region which harbors a 900kb inversion polymorphism ###molecularBasis,Caused by mutation in the KAT8 regulatory NSL complex subunit 1 gene (KANSL1, );###molecularBasis,Contiguous gene syndrome caused by microdeletion (600-800kb) of chromosome 17q21.31 encompassing genes CRHR1 ()",https://www.omim.org/entry/610443,.,Autosomal dominant,Het,17,44248734,C,G,.,.,PASS,0/1:38:95,40.0,",g,,g,,g,GgGgg.,.G,gG,Gg,G..G,,.gGg..G....gG,.,,.g,..,g.G...G,..G...g.GG,,,G.,,,,G,gGG",missense_variant;missense_variant;missense_variant,KANSL1,284058,.,NM_001193466.1(KANSL1):c.776G>C(p.Gly259Ala);NM_015443.3(KANSL1):c.776G>C(p.Gly259Ala);NM_001193465.1(KANSL1):c.776G>C(p.Gly259Ala),NM_001193466.1,exon2(15);exon2(15);exon3(16),P0=>NP;P0=>NP;P0=>NP,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,0.49,36.5,3,1.0,http://exac.broadinstitute.org/gene/ENSG00000120071,0.08931,.,0.76,T,0.004,B,0.009,B,0.141,N,1.000,D,3.91,4.660,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,chromatin organization (GO:0006325)|histone H4-K16 acetylation (GO:0043984)|histone H4-K5 acetylation (GO:0043981)|histone H4-K8 acetylation (GO:0043982),histone acetyltransferase complex (GO:0000123)|MLL1 complex (GO:0071339)|nucleoplasm (GO:0005654)|nucleus (GO:0005634),.,.,.,.,.,43,6,NFS17007000102
217,.,.,OMIM|low_frequency,.,.,NFS17007000102,252500;252600,Mucolipidosis II alpha/beta;Mucolipidosis III alpha/beta,"1.$$$mimNumber,252500###prefix,####preferredTitle,MUCOLIPIDOSIS II ALPHA/BETA###inheritance,Autosomal recessive ###growthHeight,Birth length less than normal ;###growthHeight,Deceleration of linear growth during first year ###growthWeight,Birth weight less than normal ###growthOther,Progressive failure to thrive ;###growthOther,Hurler-like body configuration ;###growthOther,Marked growth retardation ###headAndNeckFace,High, narrow forehead ;###headAndNeckFace,Long philtrum ;###headAndNeckFace,Coarse facial features ###headAndNeckEars,Recurrent episodes of otitis media ;###headAndNeckEars,Thick, firm earlobes ###headAndNeckEyes,Thin eyebrows ;###headAndNeckEyes,Puffy eyelids ;###headAndNeckEyes,Epicanthal folds ;###headAndNeckEyes,Clear to faintly hazy corneas ;###headAndNeckEyes,Increased corneal diameter ;###headAndNeckEyes,Corneal opacities on slit-lamp examination ###headAndNeckNose,Low nasal bridge ;###headAndNeckNose,Anteverted nostrils ###headAndNeckMouth,Progressive alveolar ridge hypertropy ;###headAndNeckMouth,Macroglossia ###cardiovascularHeart,Congestive heart failure ;###cardiovascularHeart,Hypertrophic cardiomyopathy ;###cardiovascularHeart,Cardiomegaly ;###cardiovascularHeart,Cardiac murmur ;###cardiovascularHeart,Aortic insufficiency ###respiratoryAirways,Recurrent bronchitis ###respiratoryLung,Recurrent pneumonia ###chestExternalFeatures,Widely spaced nipples ###chestRibsSternumClaviclesAndScapulae,Scapular hypoplasia ;###chestRibsSternumClaviclesAndScapulae,Broad, spatulate-appearing ribs ###abdomenExternalFeatures,Diastasis recti ;###abdomenExternalFeatures,Abdominal protuberance ;###abdomenExternalFeatures,Umbilical hernia ###abdomenLiver,Hepatomegaly ###abdomenSpleen,Minimal splenomegaly ###genitourinaryExternalGenitaliaMale,Inguinal hernia ###skeletal,Moderate joint limitation ;###skeletal,Osteopenia in early infancy ;###skeletal,Pathologic fractures ###skeletalSkull,Thickened cranium ;###skeletalSkull,Normal enlarged sella turcica ###skeletalSpine,Dorsolumbar kyphosis ;###skeletalSpine,Atlantoaxial dislocation ;###skeletalSpine,Ovoid vertebral bodies ;###skeletalSpine,Narrowness of interpediculate distances in lower thoracic regions ;###skeletalSpine,Hypoplastic odontoid process ;###skeletalSpine,Beaking of vertebral bodies T12-L3 ;###skeletalSpine,Lumbar gibbus ###skeletalPelvis,Flared iliac wings ;###skeletalPelvis,Horizontal acetabular roofs ;###skeletalPelvis,Supra-acetabular constriction ;###skeletalPelvis,Hip dislocation ;###skeletalPelvis,Irregular contours of pubis and ischium ###skeletalLimbs,Cortical bone erosion (especially proximal femora) ;###skeletalLimbs,Long bone shortening ;###skeletalLimbs,Widened metaphyses ;###skeletalLimbs,Varus deformity of humeral neck ;###skeletalLimbs,Tilted distal ends of radius and ulna ###skeletalHands,Broadening of wrist ;###skeletalHands,Brachyphalangia ;###skeletalHands,Hypoplasia of carpal bones ;###skeletalHands,Conical bullet-shaped distal ends of phalanges ;###skeletalHands,Claw-hand deformities ###skeletalFeet,Talipes equinovarus ###skinNailsHairSkin,Thick, relatively tight skin ;###skinNailsHairSkin,Cavernous hemangioma ###neurologicCentralNervousSystem,Severe psychomotor retardation ;###neurologicCentralNervousSystem,Developmental delay ;###neurologicCentralNervousSystem,Myelopathy ;###neurologicCentralNervousSystem,Neonatal hypotonia ###voice,Hoarse voice ###laboratoryAbnormalities,Normal to mildly increased mucopolysacchariduria ;###laboratoryAbnormalities,Increased serum beta-hexosaminidase (10-20x) ;###laboratoryAbnormalities,Increased serum iduronate sulfatase (10-20x) ;###laboratoryAbnormalities,Increased serum arylsulfatase A (10-20x) ;###laboratoryAbnormalities,Deficiency of N-acetylglucosamine-1-phosphotransferase ;###laboratoryAbnormalities,Inclusion bodies (membrane-bound vacuoles) in fibroblasts ###miscellaneous,Death in childhood ;###miscellaneous,Death often secondary to pneumonia or congestive heart failure ;###miscellaneous,Carrier rate of 1 in 39 in the Saguenay-Lac-Saint-Jean region of Quebec ###molecularBasis,Caused by mutation in the N-acetylglucosamine-1-phosphotransferase, alpha/beta subunits gene (GNPTAB, ) 2.$$$mimNumber,252600###prefix,####preferredTitle,MUCOLIPIDOSIS III ALPHA/BETA###inheritance,Autosomal recessive ###growthHeight,Short stature ###headAndNeckFace,Mildly coarse facies ###headAndNeckEyes,Corneal clouding ;###headAndNeckEyes,Mild retinopathy ;###headAndNeckEyes,Hyperopic astigmatism ###cardiovascularHeart,Aortic insufficiency ###chestRibsSternumClaviclesAndScapulae,Short, thick clavicles ;###chestRibsSternumClaviclesAndScapulae,Wide, slightly short ribs ###skeletal,Dysostosis multiplex ###skeletalSkull,Premature closure of cranial sutures ;###skeletalSkull,J-shaped sella turcica ;###skeletalSkull,Mandibular prognathism ###skeletalSpine,Scoliosis ;###skeletalSpine,Absence of dens ;###skeletalSpine,Vertebral beaking ###skeletalPelvis,Flaring of iliac wings ;###skeletalPelvis,Shallow acetabular fossae ###skeletalLimbs,Shoulder stiffness ;###skeletalLimbs,Broad metaphyses ;###skeletalLimbs,Short long bones ###skeletalHands,Hand stiffness ;###skeletalHands,Claw-hand deformities ;###skeletalHands,Carpal tunnel syndrome ;###skeletalHands,Soft tissue swelling of interphalangeal joints ;###skeletalHands,Small, irregular carpal bones ###skinNailsHairSkin,Skin thickening ###neurologicCentralNervousSystem,Learning disabilities ;###neurologicCentralNervousSystem,Mental retardation ###laboratoryAbnormalities,No mucopolysacchariduria ;###laboratoryAbnormalities,Increased serum beta-hexosaminidase (10-20x) ;###laboratoryAbnormalities,Increased serum iduronate sulfatase (10-20x) ;###laboratoryAbnormalities,Increased serum aryl-sulfatase A (10-20x) ;###laboratoryAbnormalities,Deficiency of N-acetylglucosamine-1-phosphotransferase ###miscellaneous,Symptoms noted at 2-3 years ;###miscellaneous,Allelic to mucolipidosis II ()###molecularBasis,Caused by mutation in the N-acetylglucosamine-1-phosphotransferase, alpha/beta subunits gene (GNPTAB, )",https://www.omim.org/entry/252500;https://www.omim.org/entry/252600,.,Autosomal recessive,Het,12,102158945,G,T,.,.,PASS,0/1:46:100,46.0,".,,,ttt,,.,.t.t.ttTTT.Tttt,t...T,TtT...,,,,t....TTtTt.t,TTTTtT,ttT.,.TT.T....T....T..t^],",missense_variant,GNPTAB,79158,.,NM_024312.4(GNPTAB):c.1750C>A(p.Pro584Thr),NM_024312.4,exon13(21),NP=>P0,0.006,0.0012,0,0,0.0006,0.0083,0.0004,0.0074,0,77,0.0089,0,77,0.00063,0.0348360655738,17/488,http://exac.broadinstitute.org/variant/12-102158945-G-T,0.59,43.1,17,0.0,http://exac.broadinstitute.org/gene/ENSG00000111670,0.55539,.,0.2,T,0.868,P,0.4,B,0.000,D,1.000,D,5.96,16.24,rs201829728,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,carbohydrate phosphorylation (GO:0046835)|cell differentiation (GO:0030154)|lysosome organization (GO:0007040)|protein secretion (GO:0009306),Golgi apparatus (GO:0005794)|Golgi membrane (GO:0000139)|integral component of membrane (GO:0016021)|nucleus (GO:0005634),calcium ion binding (GO:0005509)|UDP-N-acetylglucosamine-lysosomal-enzyme N-acetylglucosaminephosphotransferase activity (GO:0003976),.,.,.,.,35,5,NFS17007000102
228,.,.,OMIM|low_frequency,.,.,NFS17007000102,259600,"Multicentric osteolysis, nodulosis, and arthropathy","1.$$$mimNumber,259600###prefix,####preferredTitle,MULTICENTRIC OSTEOLYSIS, NODULOSIS, AND ARTHROPATHY; MONA###inheritance,Autosomal recessive ###skeletal,Osteoporosis ###skeletalPelvis,Flexion contracture (hip) ###skeletalLimbs,Flexion contractures (elbows and knees) ###skeletalHands,Fusiform finger swelling ;###skeletalHands,Interphalangeal joint erosions ;###skeletalHands,Finger contractures ;###skeletalHands,Carpal osteolysis ;###skeletalHands,Widened metacarpal shaft ;###skeletalHands,Thin metacarpal cortices ###skeletalFeet,Pes planus ;###skeletalFeet,Pes cavus ;###skeletalFeet,Tarsal osteolysis ;###skeletalFeet,Widened metatarsal shaft ;###skeletalFeet,Interphalangeal joint erosions ;###skeletalFeet,Thin metatarsal cortices ###skinNailsHairSkin,Subcutaneous nodules (interphalangeal joints, knees, feet, elbows, pretibial) ;###skinNailsHairSkin,Hyperpigmented erythematous lesions ###laboratoryAbnormalities,Elevated antinuclear antibody (ANA) (speckled pattern) ;###laboratoryAbnormalities,Elevated IL1-beta ;###laboratoryAbnormalities,Elevated IL6 ###miscellaneous,Abnormal gait ###molecularBasis,Caused by mutation in the matrix metalloproteinase 2 gene (MMP2, )",https://www.omim.org/entry/259600,.,Autosomal recessive,Het,16,55530864,G,A,.,.,PASS,0/1:35:72,48.61,"A.A.A.A.AA....,,.A.A,AAAa,A.A.a.AA.,,a.,A.aA.A....a,AA,..AA,A.A",missense_variant;missense_variant,MMP2,4313,.,NM_001127891.1(MMP2):c.1349G>A(p.Arg450His);NM_004530.4(MMP2):c.1499G>A(p.Arg500His),NM_004530.5,exon10(13);exon10(13),P+=>P+;P+=>P+,0.0089,0.0034,37,0.0028,0.0012,0.0091,0.0023,0.0086,0,74,0.0086,1,171,0.0014,0.00819672131148,4/488,http://exac.broadinstitute.org/variant/16-55530864-G-A,1.22,22.5,4,0.79,http://exac.broadinstitute.org/gene/ENSG00000087245,0.71373,1.16E-4,0.09,T,0.958,D,0.456,P,0.005,N,1.000,N,2.0,19.49,rs28730814,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,angiogenesis (GO:0001525)|blood vessel maturation (GO:0001955)|bone trabecula formation (GO:0060346)|cellular protein metabolic process (GO:0044267)|cellular response to amino acid stimulus (GO:0071230)|collagen catabolic process (GO:0030574)|embryo implantation (GO:0007566)|endodermal cell differentiation (GO:0035987)|extracellular matrix disassembly (GO:0022617)|extracellular matrix organization (GO:0030198)|face morphogenesis (GO:0060325)|intramembranous ossification (GO:0001957)|positive regulation of innate immune response (GO:0045089)|proteolysis (GO:0006508)|response to hypoxia (GO:0001666),extracellular region (GO:0005576)|extracellular space (GO:0005615)|mitochondrion (GO:0005739)|nucleus (GO:0005634)|plasma membrane (GO:0005886)|proteinaceous extracellular matrix (GO:0005578)|sarcomere (GO:0030017),metalloendopeptidase activity (GO:0004222)|serine-type endopeptidase activity (GO:0004252)|zinc ion binding (GO:0008270),.,.,.,.,56,7,NFS17007000102
240,.,.,OMIM|low_frequency,.,.,NFS17007000102,600972;256050;222600;226900,"Achondrogenesis Ib;Atelosteogenesis II;De la Chapelle dysplasia;Diastrophic dysplasia;Diastrophic dysplasia, broad bone-platyspondylic variant;Epiphyseal dysplasia, multiple, 4","1.$$$mimNumber,600972###prefix,####preferredTitle,ACHONDROGENESIS, TYPE IB; ACG1B###inheritance,Autosomal recessive ###growthHeight,Short-limbed dwarfism identifiable at birth ###growthOther,Fetal hydrops ###headAndNeckHead,Flat face ###respiratoryLung,Respiratory insufficiency ###chestExternalFeatures,Narrow chest ###chestRibsSternumClaviclesAndScapulae,Thin short ribs ;###chestRibsSternumClaviclesAndScapulae,Occasional rib fractures ###abdomenExternalFeatures,Umbilical hernia ;###abdomenExternalFeatures,Inguinal herniae ;###abdomenExternalFeatures,Distended abdomen ###skeletalSkull,Slightly less ossified than expected for gestational age ###skeletalSpine,Absent or minimally ossified vertebral bodies ###skeletalPelvis,Small iliac bones ;###skeletalPelvis,Unossified ischium and pubis ###skeletalLimbs,Severe micromelia ;###skeletalLimbs,Marked shortness, broad tubular bone ;###skeletalLimbs,Metaphyseal spurring ###prenatalManifestationsAmnioticFluid,Polyhydramnios ###prenatalManifestationsDelivery,Breech presentation at birth ;###prenatalManifestationsDelivery,Often stillborn ###laboratoryAbnormalities,No cartilage staining with toluidine blue ;###laboratoryAbnormalities,Impaired synthesis of fibroblast sulfated proteoglycans ###molecularBasis,Caused by mutation in the solute carrier family 26 (sulfate transporter), member 2 gene (SLC26A2, ) 2.$$$mimNumber,256050###prefix,####preferredTitle,ATELOSTEOGENESIS, TYPE II; AO2###inheritance,Autosomal recessive ###headAndNeckFace,Midface hypoplasia ;###headAndNeckFace,Micrognathia ###headAndNeckNose,Flattened nasal bridge ###headAndNeckMouth,Cleft palate ###headAndNeckNeck,Short neck ###respiratoryLung,Respiratory insufficiency ;###respiratoryLung,Pulmonary hypoplasia ###chestRibsSternumClaviclesAndScapulae,Small thorax ###skeletalSpine,Cervical kyphosis ;###skeletalSpine,Platyspondyly ;###skeletalSpine,Vertebral body coronal clefts ;###skeletalSpine,Scoliosis ;###skeletalSpine,Lumbar hyperlordosis ;###skeletalSpine,Horizontal sacrum ###skeletalPelvis,Round-shaped iliac bones ;###skeletalPelvis,Flat acetabulae ;###skeletalPelvis,Shortened sacroiliac notches ###skeletalLimbs,Severe micromelia ;###skeletalLimbs,Bifid distal humerus ;###skeletalLimbs,Short, dumbbell femur ;###skeletalLimbs,Abducted thumbs and great toes ;###skeletalLimbs,Gap between first and second toe ;###skeletalLimbs,Hypoplastic, rounded middle phalanges ;###skeletalLimbs,Talipes equinovarus ###prenatalManifestationsDelivery,Stillborn or death shortly after birth ###laboratoryAbnormalities,Lacunar halos around chondrocytes in skeletal cartilage ###miscellaneous,Allelic to diastrophic dysplasia ()###molecularBasis,Caused by mutation in the solute carrier family 26 (sulfate transporter), member 2 gene (SLC26A2, ) 3.$$$mimNumber,222600###prefix,####preferredTitle,DIASTROPHIC DYSPLASIA; DTD###inheritance,Autosomal recessive ###growthHeight,Mean birth length 42cm, specific growth curve available ;###growthHeight,Adult height 100-140cm ###growthOther,Short-limb dwarfism identifiable at birth ###headAndNeckHead,Normocephaly ###headAndNeckEars,Neonatal cystic lesions of the pinnae ;###headAndNeckEars,Hypertrophic auricular cartilage ;###headAndNeckEars,Ossified pinnae ;###headAndNeckEars,Hearing loss ###headAndNeckMouth,Cleft palate ###respiratory,Laryngotracheal stenosis ###chest,Costal cartilage calcification ###skeletalSpine,Kyphoscoliosis ;###skeletalSpine,Hypoplastic cervical vertebrae ;###skeletalSpine,Cervical kyphosis ###skeletalPelvis,Hip contractures ###skeletalLimbs,Short, thick tubular bone, with broad metaphyses and flattened, irregular epiphyses ;###skeletalLimbs,Subluxed patella ###skeletalHands,Short finger with ulnar deviation ;###skeletalHands,Hitchhiker thumb ###skeletalFeet,Talipes equinovarus ###skinNailsHairSkin,Glabellar hemangioma ###neurologicCentralNervousSystem,Normal intelligence ;###neurologicCentralNervousSystem,Spinal cord compression ###voice,Characteristic hoarse voice ###miscellaneous,Allelic to atelosteogenesis, type II ()###molecularBasis,Caused by mutations in the solute carrier family 26 (sulfate transporter), member 2 gene (SLC26A2, ) 4.$$$mimNumber,226900###prefix,####preferredTitle,EPIPHYSEAL DYSPLASIA, MULTIPLE, 4; EDM4###inheritance,Autosomal recessive ###growthHeight,Short stature (3rd-90th centile, infrequent finding) ###skeletal,Multiple epiphyseal dysplasia ###skeletalSpine,Scoliosis ###skeletalPelvis,Hip dysplasia ;###skeletalPelvis,Small femoral heads ;###skeletalPelvis,Flattened proximal femoral epiphyses ###skeletalLimbs,Limited elbow flexion ;###skeletalLimbs,Double layered patella ;###skeletalLimbs,Arthralgia ;###skeletalLimbs,Small humeral, distal radii, and ulnae epiphyses ;###skeletalLimbs,Mildly shortened ulna ;###skeletalLimbs,Flat proximal femoral epiphyses ###skeletalHands,Brachydactyly ;###skeletalHands,Mild shortened metacarpals ###skeletalFeet,Clubfoot ###miscellaneous,Genetic heterogeneity, see EDM1 ();###miscellaneous,Allelic to diastrophic dysplasia ()###molecularBasis,Caused by mutation in the solute carrier family 26 (sulfate transporter), member 2 gene (SLC26A2, )",https://www.omim.org/entry/600972;https://www.omim.org/entry/256050;https://www.omim.org/entry/222600;https://www.omim.org/entry/226900,.,Autosomal recessive,Het,5,149357408,A,G,.,.,PASS,0/1:39:106,36.79,",,GG,G$,,,G,,Ggg.Gg.,,,gG..,,,.,GG.g.G,,.G..,,,g,,,GG,,,,.,g,Gg.G......,.g..,GG...,G..g..G,G.",missense_variant,SLC26A2,1836,.,NM_000112.3(SLC26A2):c.193A>G(p.Asn65Asp),NM_000112.3,exon2(3),P0=>P-,.,.,0,0,0.0001,0,9.683e-05,0,0,0,0,0,17,0.00014,.,.,http://exac.broadinstitute.org/variant/5-149357408-A-G,-1.37,9.8,8,0.0,http://exac.broadinstitute.org/gene/ENSG00000155850,0.04231,.,0.62,T,0.0,B,0.001,B,0.688,N,1.000,N,0.405,1.678,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,3'-phosphoadenosine 5'-phosphosulfate biosynthetic process (GO:0050428)|3'-phosphoadenosine 5'-phosphosulfate metabolic process (GO:0050427)|carbohydrate metabolic process (GO:0005975)|glycosaminoglycan metabolic process (GO:0030203)|ion transport (GO:0006811)|ossification (GO:0001503)|small molecule metabolic process (GO:0044281)|sulfate transmembrane transport (GO:1902358)|sulfate transport (GO:0008272)|transmembrane transport (GO:0055085)|xenobiotic metabolic process (GO:0006805),extracellular vesicular exosome (GO:0070062)|integral component of plasma membrane (GO:0005887)|membrane (GO:0016020)|plasma membrane (GO:0005886),secondary active sulfate transmembrane transporter activity (GO:0008271)|sulfate transmembrane transporter activity (GO:0015116),.,.,.,.,63,8,NFS17007000102
253,.,.,HGMD|OMIM,.,.,NFS17007000102,612591;615381,"Colorectal cancer, susceptibility to, 10;Mandibular hypoplasia, deafness, progeroid features, and lipodystrophy syndrome","1.$$$mimNumber,612591###prefix,####preferredTitle,COLORECTAL CANCER, SUSCEPTIBILITY TO, 10; CRCS10###inheritance,Autosomal dominant ###abdomenGastrointestinal,Colorectal adenomas ;###abdomenGastrointestinal,Colorectal polyps ;###abdomenGastrointestinal,Colorectal carcinoma ###genitourinaryInternalGenitaliaFemale,Endometrial carcinoma ###neoplasia,Colorectal carcinoma ;###neoplasia,Endometrial carcinoma ###miscellaneous,Tumors are microsatellite stable ;###miscellaneous,Onset usually before age 40 years ;###miscellaneous,Patients develop multiple tumors ###molecularBasis,Caused by mutation in the polymerase (DNA-directed), delta 1, catalytic subunit gene (POLD1, ) 2.$$$mimNumber,615381###prefix,####preferredTitle,MANDIBULAR HYPOPLASIA, DEAFNESS, PROGEROID FEATURES, AND LIPODYSTROPHY SYNDROME; MDPL###inheritance,Autosomal dominant ###growthWeight,Normal birth weight ###headAndNeckFace,Mandibular hypoplasia ;###headAndNeckFace,Progeroid appearance ###headAndNeckEars,Sensorineural deafness ###headAndNeckEyes,Prominent eyes ###headAndNeckNose,Beaked nose ###headAndNeckMouth,Small mouth ###headAndNeckTeeth,Crowded teeth ###chestBreasts,Poor breast development (in women) ###abdomenLiver,Hepatomegaly ;###abdomenLiver,Hepatic steatosis ###genitourinaryInternalGenitaliaMale,Cryptorchidism ###skeletal,Osteoporosis ;###skeletal,Joint contractures ###skeletalSpine,Kyphosis ;###skeletalSpine,Scoliosis ###skinNailsHairSkin,Tight skin ;###skinNailsHairSkin,Scleroderma-like changes ;###skinNailsHairSkin,Telangiectases ;###skinNailsHairSkin,Skin atrophy ###muscleSoftTissue,Lipodystrophy ;###muscleSoftTissue,Loss of subcutaneous fat, particularly affecting the limbs ;###muscleSoftTissue,Loss of subcutaneous fat, generalized ;###muscleSoftTissue,Increased visceral fat ###voice,High-pitched voice ###endocrineFeatures,Insulin resistance ;###endocrineFeatures,Diabetes mellitus ;###endocrineFeatures,Hypogonadism (in males) ###laboratoryAbnormalities,Abnormal liver function tests ;###laboratoryAbnormalities,Hypertriglyceridemia ###miscellaneous,Onset of lipodystrophy in early childhood ;###miscellaneous,Onset of hearing loss in first or second decade ###molecularBasis,Caused by mutation in the polymerase (DNA-directed), delta 1, catalytic subunit gene (POLD1, )",https://www.omim.org/entry/612591;https://www.omim.org/entry/615381,.,Autosomal dominant,Het,19,50902164,G,A,.,.,PASS,0/1:46:100,46.0,"..A,.AA.Aa,Aa,.,AA.,,AA.,.aaAA.Aa..A.,a.A..,aa....,A.a.A,aA,....,A.a.a,.A.aAAa,,AA.aa",missense_variant;missense_variant,POLD1,5424,.,NM_001256849.1(POLD1):c.56G>A(p.Arg19His);NM_002691.3(POLD1):c.56G>A(p.Arg19His),NM_002691.3,exon2(27);exon2(27),P+=>P+;P+=>P+,0.036,0.009,7,0.00054,0.0053,0.0345,0.0023,0.0333,3,235,0.046,6,434,0.0069,0.0758196721311,37/488,http://exac.broadinstitute.org/variant/19-50902164-G-A,2.79,32.9,11,0.0,http://exac.broadinstitute.org/gene/ENSG00000062822,0.26949,3.49E-4,0.08,T,0.001,B,0.001,B,0.460,U,0.779,D,3.12,10.98,rs3218773,.,.,.,.,NM_002691.3(POLD1):c.56G>A(p.R19H),DM?,Endometrioid endometrial carcinoma,26748215,.,.,.,.,"NM_002691.3(POLD1):c.55C>T(p.R19C),DM?,Colorectal adenoma/carcinoma,25529843",.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,"base-excision repair (GO:0006284)|base-excision repair, gap-filling (GO:0006287)|DNA repair (GO:0006281)|DNA replication (GO:0006260)|DNA replication proofreading (GO:0045004)|DNA replication, removal of RNA primer (GO:0043137)|DNA strand elongation involved in DNA replication (GO:0006271)|DNA synthesis involved in DNA repair (GO:0000731)|fatty acid homeostasis (GO:0055089)|mitotic cell cycle (GO:0000278)|nucleotide-excision repair (GO:0006289)|nucleotide-excision repair, DNA gap filling (GO:0006297)|regulation of mitotic cell cycle (GO:0007346)|response to UV (GO:0009411)|small molecule metabolic process (GO:0044281)|telomere maintenance (GO:0000723)|telomere maintenance via recombination (GO:0000722)|telomere maintenance via semi-conservative replication (GO:0032201)|transcription-coupled nucleotide-excision repair (GO:0006283)",aggresome (GO:0016235)|cytoplasm (GO:0005737)|delta DNA polymerase complex (GO:0043625)|membrane (GO:0016020)|nucleoplasm (GO:0005654)|nucleotide-excision repair complex (GO:0000109)|nucleus (GO:0005634),"3'-5' exonuclease activity (GO:0008408)|4 iron, 4 sulfur cluster binding (GO:0051539)|chromatin binding (GO:0003682)|DNA binding (GO:0003677)|DNA-directed DNA polymerase activity (GO:0003887)|metal ion binding (GO:0046872)|nucleotide binding (GO:0000166)",.,.,.,.,70,9,NFS17007000102
290,.,.,HGMD|OMIM|possible_comhet,.,.,NFS17007000102,607785;162210;162200;601321;193520,"Leukemia, juvenile myelomonocytic;Neurofibromatosis, familial spinal;Neurofibromatosis, type 1;Neurofibromatosis-Noonan syndrome;Watson syndrome","1.$$$mimNumber,607785###prefix,####preferredTitle,JUVENILE MYELOMONOCYTIC LEUKEMIA; JMML###inheritance,Autosomal dominant ;###inheritance,Somatic mutation ###hematology,Juvenile myelomonocytic leukemia ###miscellaneous,One family has been reported with germline CBL mutation (last curated May 2016)###molecularBasis,Caused by mutation in the CBL gene (CBL, );###molecularBasis,Caused by mutation in the NF1 gene (NF1, );###molecularBasis,Caused by somatic mutation in the RHO GTPase-activating protein 26 gene (ARHGAP26, 605370.0001});###molecularBasis,Caused by somatic mutation in the protein tyrosine phosphatase, nonreceptor-type, 11 gene (PTPN11, 176876.0014});###molecularBasis,Caused by somatic mutation in the neuroblastoma Ras viral oncogene (NRAS, 164790.0003});###molecularBasis,Caused by somatic mutation in the Kirsten rat sarcoma-2 viral (v-Ki-ras2) oncogene homolog gene (KRAS, ) 2.$$$mimNumber,162210###prefix,####preferredTitle,NEUROFIBROMATOSIS, FAMILIAL SPINAL###inheritance,Autosomal dominant ###headAndNeckEyes,Lisch nodules (iris hamartomas) may or may not be present ###skinNailsHairSkin,Neurofibromas may or may not be present ;###skinNailsHairSkin,Cafe-au-lait spots may or may not be present ;###skinNailsHairSkin,Freckling may or may not be present ###neurologicCentralNervousSystem,Spinal nerve root neurofibromas, symmetric, multiple ;###neurologicCentralNervousSystem,Neurofibromas can occur at cervical, thoracic, lumbar, and sacral levels ;###neurologicCentralNervousSystem,Paraparesis ;###neurologicCentralNervousSystem,Lower extremity weakness ###miscellaneous,Spinal tumors are necessary for diagnosis ;###miscellaneous,Other features of neurofibromatosis type I (NF1, ) may or may not be present;###miscellaneous,Allelic disorder to NF1 ###molecularBasis,Caused by mutation in the neurofibromin gene (NF1, ) 3.$$$mimNumber,162200###prefix,####preferredTitle,NEUROFIBROMATOSIS, TYPE I; NF1###inheritance,Autosomal dominant ###headAndNeckHead,Macrocephaly ;###headAndNeckHead,Sphenoid dysplasia ###headAndNeckEyes,Lisch nodules (iris hamartomas) ;###headAndNeckEyes,Glaucoma ;###headAndNeckEyes,Hypertelorism ;###headAndNeckEyes,Hyperreflective choroidal spots in the posterior pole###cardiovascularVascular,Renal artery stenosis ;###cardiovascularVascular,Hypertension ###skeletalSpine,Scoliosis ;###skeletalSpine,Spina bifida ###skeletalLimbs,Pseudoarthrosis ;###skeletalLimbs,Thinning of long bone cortex ;###skeletalLimbs,Local bony overgrowth ###skinNailsHairSkin,Neurofibromas ;###skinNailsHairSkin,Plexiform neurofibroma ;###skinNailsHairSkin,Cafe-au-lait spots ;###skinNailsHairSkin,Axillary freckling ;###skinNailsHairSkin,Inguinal freckling ###neurologicCentralNervousSystem,Learning disabilities (30%) ;###neurologicCentralNervousSystem,Mental retardation, mild (10%) ;###neurologicCentralNervousSystem,Aqueductal stenosis ;###neurologicCentralNervousSystem,Hydrocephalus ###neoplasia,Optic glioma ;###neoplasia,Meningioma ;###neoplasia,Hypothalamic tumor ;###neoplasia,Neurofibrosarcoma ;###neoplasia,Rhabdomyosarcoma ;###neoplasia,Duodenal carcinoid ;###neoplasia,Somatostatinoma ;###neoplasia,Parathyroid adenoma ;###neoplasia,Pheochromocytoma ;###neoplasia,Pilocytic astrocytoma ;###neoplasia,Malignant peripheral nerve sheath tumors ;###neoplasia,Tumors at multiple other sites including CNS ###miscellaneous,50% of cases are de novo ;###miscellaneous,Sporadic occurrence is associated with advanced paternal age ;###miscellaneous,Prevalence of 1 in 3,000 ###molecularBasis,Caused by mutation in the neurofibromin gene (NF1, ) 4.$$$mimNumber,601321###prefix,####preferredTitle,NEUROFIBROMATOSIS-NOONAN SYNDROME; NFNS###inheritance,Autosomal dominant ###growthHeight,Short stature ###headAndNeckHead,Macrocephaly ###headAndNeckFace,Midface hypoplasia ;###headAndNeckFace,Prominent nasolabial folds ###headAndNeckEars,Low-set ears ;###headAndNeckEars,Posteriorly rotated ears ###headAndNeckEyes,Hypertelorism ;###headAndNeckEyes,Downslanted palpebral fissures ;###headAndNeckEyes,Ptosis ;###headAndNeckEyes,Epicanthal folds ;###headAndNeckEyes,Lisch nodules ###headAndNeckNose,Low nasal root ###headAndNeckNeck,Webbed neck ;###headAndNeckNeck,Short neck ;###headAndNeckNeck,Webbed neck ###cardiovascularHeart,Pulmonic stenosis ###chestExternalFeatures,Pectus carinatum superiorly ;###chestExternalFeatures,Pectus excavatum inferiorly ###genitourinaryInternalGenitaliaMale,Cryptorchidism ###skeletalSpine,Scoliosis ###skeletalLimbs,Cubitus valgus ###skinNailsHairSkin,Cafe-au-lait spots ;###skinNailsHairSkin,Axillary freckling ;###skinNailsHairSkin,Inguinal freckling ;###skinNailsHairSkin,Neurofibromas ###skinNailsHairHair,Low posterior hairline ;###skinNailsHairHair,Frontal upsweep of the hair ###neurologicCentralNervousSystem,Speech delay ;###neurologicCentralNervousSystem,Articulation defects ;###neurologicCentralNervousSystem,Developmental delay, mild ;###neurologicCentralNervousSystem,Unidentified bright objects on brain MRI ###neoplasia,Optic glioma ;###neoplasia,Neurofibromas ;###neoplasia,Low incidence of plexiform neurofibromas ###miscellaneous,Phenotypic overlap between neurofibromatosis type 1 ()###molecularBasis,Caused by mutation in the neurofibromin gene (NF1, ) 5.$$$mimNumber,193520###prefix,####preferredTitle,WATSON SYNDROME; WTSN###inheritance,Autosomal dominant ###growthHeight,Short stature ###headAndNeckHead,Relative macrocephaly ###headAndNeckEyes,Lisch nodules ###cardiovascularHeart,Pulmonary valvular stenosis ###skinNailsHairSkin,Multiple cafe-au-lait spots ;###skinNailsHairSkin,Neurofibromas ;###skinNailsHairSkin,Axillary freckling ###neurologicCentralNervousSystem,Low IQ ###miscellaneous,Allelic to neurofibromatosis-1 (NF1, )###molecularBasis,Caused by mutations in the neurofibromin gene (NF1, )",https://www.omim.org/entry/607785;https://www.omim.org/entry/162210;https://www.omim.org/entry/162200;https://www.omim.org/entry/601321;https://www.omim.org/entry/193520,.,"Autosomal dominant, Somatic mutation;Autosomal dominant",Het,17,29677247,A,G,.,.,PASS,0/1:26:74,35.14,".,.ggG...,,G,G,....,G.ggg,GgG..,G....,G.,ggg,..,GG,,.Gg.G..G^].^].",synonymous_variant;synonymous_variant,NF1,4763,.,NM_000267.3(NF1):c.7305A>G(p.Lys2435=);NM_001042492.2(NF1):c.7368A>G(p.Lys2456=),NM_000267.3,exon49(57);exon50(58),.;.,0.002,0.0004,0,0,0.0005,0.0059,0.0003,0.0043,0,45,0.0052,0,50,0.00041,0.0184426229508,9/488,http://exac.broadinstitute.org/variant/17-29677247-A-G,6.22,104.9,14,1.0,http://exac.broadinstitute.org/gene/ENSG00000196712,.,.,.,.,.,.,.,.,.,.,.,.,.,.,rs201287021,.,.,.,.,.,.,.,.,.,.,.,.,"NM_000267.3(NF1):c.7305delA,DM,Neurofibromatosis 1,25074460",184263,https://www.ncbi.nlm.nih.gov/clinvar/variation/184263,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,"actin cytoskeleton organization (GO:0030036)|adrenal gland development (GO:0030325)|artery morphogenesis (GO:0048844)|brain development (GO:0007420)|camera-type eye morphogenesis (GO:0048593)|cell communication (GO:0007154)|cerebral cortex development (GO:0021987)|cognition (GO:0050890)|collagen fibril organization (GO:0030199)|extracellular matrix organization (GO:0030198)|extrinsic apoptotic signaling pathway via death domain receptors (GO:0008625)|forebrain astrocyte development (GO:0021897)|forebrain morphogenesis (GO:0048853)|heart development (GO:0007507)|liver development (GO:0001889)|MAPK cascade (GO:0000165)|metanephros development (GO:0001656)|myelination in peripheral nervous system (GO:0022011)|negative regulation of angiogenesis (GO:0016525)|negative regulation of astrocyte differentiation (GO:0048712)|negative regulation of cell migration (GO:0030336)|negative regulation of cell-matrix adhesion (GO:0001953)|negative regulation of endothelial cell proliferation (GO:0001937)|negative regulation of fibroblast proliferation (GO:0048147)|negative regulation of MAP kinase activity (GO:0043407)|negative regulation of MAPK cascade (GO:0043409)|negative regulation of neuroblast proliferation (GO:0007406)|negative regulation of neurotransmitter secretion (GO:0046929)|negative regulation of oligodendrocyte differentiation (GO:0048715)|negative regulation of osteoclast differentiation (GO:0045671)|negative regulation of protein kinase activity (GO:0006469)|negative regulation of Rac protein signal transduction (GO:0035021)|negative regulation of Ras protein signal transduction (GO:0046580)|negative regulation of transcription factor import into nucleus (GO:0042992)|neural tube development (GO:0021915)|osteoblast differentiation (GO:0001649)|peripheral nervous system development (GO:0007422)|phosphatidylinositol 3-kinase signaling (GO:0014065)|pigmentation (GO:0043473)|positive regulation of adenylate cyclase activity (GO:0045762)|positive regulation of apoptotic process (GO:0043065)|positive regulation of endothelial cell proliferation (GO:0001938)|positive regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001241)|positive regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902043)|positive regulation of neuron apoptotic process (GO:0043525)|positive regulation of Ras GTPase activity (GO:0032320)|Ras protein signal transduction (GO:0007265)|regulation of angiogenesis (GO:0045765)|regulation of blood vessel endothelial cell migration (GO:0043535)|regulation of bone resorption (GO:0045124)|regulation of cell-matrix adhesion (GO:0001952)|regulation of glial cell differentiation (GO:0045685)|regulation of long-term neuronal synaptic plasticity (GO:0048169)|regulation of Ras GTPase activity (GO:0032318)|regulation of synaptic transmission, GABAergic (GO:0032228)|response to hypoxia (GO:0001666)|Schwann cell development (GO:0014044)|skeletal muscle tissue development (GO:0007519)|smooth muscle tissue development (GO:0048745)|spinal cord development (GO:0021510)|sympathetic nervous system development (GO:0048485)|visual learning (GO:0008542)|wound healing (GO:0042060)",axon (GO:0030424)|cytoplasm (GO:0005737)|dendrite (GO:0030425)|intrinsic component of the cytoplasmic side of the plasma membrane (GO:0031235)|membrane (GO:0016020)|nucleus (GO:0005634),phosphatidylcholine binding (GO:0031210)|phosphatidylethanolamine binding (GO:0008429)|Ras GTPase activator activity (GO:0005099),.,.,.,.,0,0,NFS17007000102
318,.,.,OMIM|truncating|novel|possible_comhet,.,.,NFS17007000102,607785;162210;162200;601321;193520,"Leukemia, juvenile myelomonocytic;Neurofibromatosis, familial spinal;Neurofibromatosis, type 1;Neurofibromatosis-Noonan syndrome;Watson syndrome","1.$$$mimNumber,607785###prefix,####preferredTitle,JUVENILE MYELOMONOCYTIC LEUKEMIA; JMML###inheritance,Autosomal dominant ;###inheritance,Somatic mutation ###hematology,Juvenile myelomonocytic leukemia ###miscellaneous,One family has been reported with germline CBL mutation (last curated May 2016)###molecularBasis,Caused by mutation in the CBL gene (CBL, );###molecularBasis,Caused by mutation in the NF1 gene (NF1, );###molecularBasis,Caused by somatic mutation in the RHO GTPase-activating protein 26 gene (ARHGAP26, 605370.0001});###molecularBasis,Caused by somatic mutation in the protein tyrosine phosphatase, nonreceptor-type, 11 gene (PTPN11, 176876.0014});###molecularBasis,Caused by somatic mutation in the neuroblastoma Ras viral oncogene (NRAS, 164790.0003});###molecularBasis,Caused by somatic mutation in the Kirsten rat sarcoma-2 viral (v-Ki-ras2) oncogene homolog gene (KRAS, ) 2.$$$mimNumber,162210###prefix,####preferredTitle,NEUROFIBROMATOSIS, FAMILIAL SPINAL###inheritance,Autosomal dominant ###headAndNeckEyes,Lisch nodules (iris hamartomas) may or may not be present ###skinNailsHairSkin,Neurofibromas may or may not be present ;###skinNailsHairSkin,Cafe-au-lait spots may or may not be present ;###skinNailsHairSkin,Freckling may or may not be present ###neurologicCentralNervousSystem,Spinal nerve root neurofibromas, symmetric, multiple ;###neurologicCentralNervousSystem,Neurofibromas can occur at cervical, thoracic, lumbar, and sacral levels ;###neurologicCentralNervousSystem,Paraparesis ;###neurologicCentralNervousSystem,Lower extremity weakness ###miscellaneous,Spinal tumors are necessary for diagnosis ;###miscellaneous,Other features of neurofibromatosis type I (NF1, ) may or may not be present;###miscellaneous,Allelic disorder to NF1 ###molecularBasis,Caused by mutation in the neurofibromin gene (NF1, ) 3.$$$mimNumber,162200###prefix,####preferredTitle,NEUROFIBROMATOSIS, TYPE I; NF1###inheritance,Autosomal dominant ###headAndNeckHead,Macrocephaly ;###headAndNeckHead,Sphenoid dysplasia ###headAndNeckEyes,Lisch nodules (iris hamartomas) ;###headAndNeckEyes,Glaucoma ;###headAndNeckEyes,Hypertelorism ;###headAndNeckEyes,Hyperreflective choroidal spots in the posterior pole###cardiovascularVascular,Renal artery stenosis ;###cardiovascularVascular,Hypertension ###skeletalSpine,Scoliosis ;###skeletalSpine,Spina bifida ###skeletalLimbs,Pseudoarthrosis ;###skeletalLimbs,Thinning of long bone cortex ;###skeletalLimbs,Local bony overgrowth ###skinNailsHairSkin,Neurofibromas ;###skinNailsHairSkin,Plexiform neurofibroma ;###skinNailsHairSkin,Cafe-au-lait spots ;###skinNailsHairSkin,Axillary freckling ;###skinNailsHairSkin,Inguinal freckling ###neurologicCentralNervousSystem,Learning disabilities (30%) ;###neurologicCentralNervousSystem,Mental retardation, mild (10%) ;###neurologicCentralNervousSystem,Aqueductal stenosis ;###neurologicCentralNervousSystem,Hydrocephalus ###neoplasia,Optic glioma ;###neoplasia,Meningioma ;###neoplasia,Hypothalamic tumor ;###neoplasia,Neurofibrosarcoma ;###neoplasia,Rhabdomyosarcoma ;###neoplasia,Duodenal carcinoid ;###neoplasia,Somatostatinoma ;###neoplasia,Parathyroid adenoma ;###neoplasia,Pheochromocytoma ;###neoplasia,Pilocytic astrocytoma ;###neoplasia,Malignant peripheral nerve sheath tumors ;###neoplasia,Tumors at multiple other sites including CNS ###miscellaneous,50% of cases are de novo ;###miscellaneous,Sporadic occurrence is associated with advanced paternal age ;###miscellaneous,Prevalence of 1 in 3,000 ###molecularBasis,Caused by mutation in the neurofibromin gene (NF1, ) 4.$$$mimNumber,601321###prefix,####preferredTitle,NEUROFIBROMATOSIS-NOONAN SYNDROME; NFNS###inheritance,Autosomal dominant ###growthHeight,Short stature ###headAndNeckHead,Macrocephaly ###headAndNeckFace,Midface hypoplasia ;###headAndNeckFace,Prominent nasolabial folds ###headAndNeckEars,Low-set ears ;###headAndNeckEars,Posteriorly rotated ears ###headAndNeckEyes,Hypertelorism ;###headAndNeckEyes,Downslanted palpebral fissures ;###headAndNeckEyes,Ptosis ;###headAndNeckEyes,Epicanthal folds ;###headAndNeckEyes,Lisch nodules ###headAndNeckNose,Low nasal root ###headAndNeckNeck,Webbed neck ;###headAndNeckNeck,Short neck ;###headAndNeckNeck,Webbed neck ###cardiovascularHeart,Pulmonic stenosis ###chestExternalFeatures,Pectus carinatum superiorly ;###chestExternalFeatures,Pectus excavatum inferiorly ###genitourinaryInternalGenitaliaMale,Cryptorchidism ###skeletalSpine,Scoliosis ###skeletalLimbs,Cubitus valgus ###skinNailsHairSkin,Cafe-au-lait spots ;###skinNailsHairSkin,Axillary freckling ;###skinNailsHairSkin,Inguinal freckling ;###skinNailsHairSkin,Neurofibromas ###skinNailsHairHair,Low posterior hairline ;###skinNailsHairHair,Frontal upsweep of the hair ###neurologicCentralNervousSystem,Speech delay ;###neurologicCentralNervousSystem,Articulation defects ;###neurologicCentralNervousSystem,Developmental delay, mild ;###neurologicCentralNervousSystem,Unidentified bright objects on brain MRI ###neoplasia,Optic glioma ;###neoplasia,Neurofibromas ;###neoplasia,Low incidence of plexiform neurofibromas ###miscellaneous,Phenotypic overlap between neurofibromatosis type 1 ()###molecularBasis,Caused by mutation in the neurofibromin gene (NF1, ) 5.$$$mimNumber,193520###prefix,####preferredTitle,WATSON SYNDROME; WTSN###inheritance,Autosomal dominant ###growthHeight,Short stature ###headAndNeckHead,Relative macrocephaly ###headAndNeckEyes,Lisch nodules ###cardiovascularHeart,Pulmonary valvular stenosis ###skinNailsHairSkin,Multiple cafe-au-lait spots ;###skinNailsHairSkin,Neurofibromas ;###skinNailsHairSkin,Axillary freckling ###neurologicCentralNervousSystem,Low IQ ###miscellaneous,Allelic to neurofibromatosis-1 (NF1, )###molecularBasis,Caused by mutations in the neurofibromin gene (NF1, )",https://www.omim.org/entry/607785;https://www.omim.org/entry/162210;https://www.omim.org/entry/162200;https://www.omim.org/entry/601321;https://www.omim.org/entry/193520,.,"Autosomal dominant, Somatic mutation;Autosomal dominant",Het,17,29490295,-,A,.,.,PASS,0/1:51:96,53.13,".$,,..,..,....+1A.+1A..+1A.,+1a.+1A,,.+1A..+1A.+1A.+1A,,+1a,.+1A.+1A,+1a,,+1a.+1A...,+1a,,.+1A.+1A,+1a..+1A,+1a.+1A.,+1a.+1A.+1A,,,+1a,....+1A,+1a,+1a.+1A,+1a,.+1A...+1A.+1A,+1a,+1a.,....+1A,+1a,+1a..+1A",frameshift_variant;frameshift_variant;frameshift_variant,NF1,4763,.,NM_000267.3(NF1):c.383dupA(p.Asn128LysfsTer6);NM_001128147.2(NF1):c.383dupA(p.Asn128LysfsTer6);NM_001042492.2(NF1):c.383dupA(p.Asn128LysfsTer6),NM_000267.3,exon4(57);exon4(15);exon4(58),.;.;.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,6.22,104.9,14,1.0,http://exac.broadinstitute.org/gene/ENSG00000196712,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,"actin cytoskeleton organization (GO:0030036)|adrenal gland development (GO:0030325)|artery morphogenesis (GO:0048844)|brain development (GO:0007420)|camera-type eye morphogenesis (GO:0048593)|cell communication (GO:0007154)|cerebral cortex development (GO:0021987)|cognition (GO:0050890)|collagen fibril organization (GO:0030199)|extracellular matrix organization (GO:0030198)|extrinsic apoptotic signaling pathway via death domain receptors (GO:0008625)|forebrain astrocyte development (GO:0021897)|forebrain morphogenesis (GO:0048853)|heart development (GO:0007507)|liver development (GO:0001889)|MAPK cascade (GO:0000165)|metanephros development (GO:0001656)|myelination in peripheral nervous system (GO:0022011)|negative regulation of angiogenesis (GO:0016525)|negative regulation of astrocyte differentiation (GO:0048712)|negative regulation of cell migration (GO:0030336)|negative regulation of cell-matrix adhesion (GO:0001953)|negative regulation of endothelial cell proliferation (GO:0001937)|negative regulation of fibroblast proliferation (GO:0048147)|negative regulation of MAP kinase activity (GO:0043407)|negative regulation of MAPK cascade (GO:0043409)|negative regulation of neuroblast proliferation (GO:0007406)|negative regulation of neurotransmitter secretion (GO:0046929)|negative regulation of oligodendrocyte differentiation (GO:0048715)|negative regulation of osteoclast differentiation (GO:0045671)|negative regulation of protein kinase activity (GO:0006469)|negative regulation of Rac protein signal transduction (GO:0035021)|negative regulation of Ras protein signal transduction (GO:0046580)|negative regulation of transcription factor import into nucleus (GO:0042992)|neural tube development (GO:0021915)|osteoblast differentiation (GO:0001649)|peripheral nervous system development (GO:0007422)|phosphatidylinositol 3-kinase signaling (GO:0014065)|pigmentation (GO:0043473)|positive regulation of adenylate cyclase activity (GO:0045762)|positive regulation of apoptotic process (GO:0043065)|positive regulation of endothelial cell proliferation (GO:0001938)|positive regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001241)|positive regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902043)|positive regulation of neuron apoptotic process (GO:0043525)|positive regulation of Ras GTPase activity (GO:0032320)|Ras protein signal transduction (GO:0007265)|regulation of angiogenesis (GO:0045765)|regulation of blood vessel endothelial cell migration (GO:0043535)|regulation of bone resorption (GO:0045124)|regulation of cell-matrix adhesion (GO:0001952)|regulation of glial cell differentiation (GO:0045685)|regulation of long-term neuronal synaptic plasticity (GO:0048169)|regulation of Ras GTPase activity (GO:0032318)|regulation of synaptic transmission, GABAergic (GO:0032228)|response to hypoxia (GO:0001666)|Schwann cell development (GO:0014044)|skeletal muscle tissue development (GO:0007519)|smooth muscle tissue development (GO:0048745)|spinal cord development (GO:0021510)|sympathetic nervous system development (GO:0048485)|visual learning (GO:0008542)|wound healing (GO:0042060)",axon (GO:0030424)|cytoplasm (GO:0005737)|dendrite (GO:0030425)|intrinsic component of the cytoplasmic side of the plasma membrane (GO:0031235)|membrane (GO:0016020)|nucleus (GO:0005634),phosphatidylcholine binding (GO:0031210)|phosphatidylethanolamine binding (GO:0008429)|Ras GTPase activator activity (GO:0005099),.,.,.,.,0,0,NFS17007000102
361,.,.,low_frequency,.,.,NFS17007000102,.,.,.,.,.,.,Het,8,145742123,G,A,.,.,PASS,0/1:32:64,50.0,",Aa.a,.A,.a,a,aAa.,aA,,aAAAA,a.a.A.,.Aa,Aa..,,AA,.Aa,a^].^].^].",missense_variant,RECQL4,9684,.,NM_004260.3(RECQL4):c.380C>T(p.Pro127Leu),NM_004260.3,exon5(21),NP=>NP,.,0.0002,0,0,5.737e-05,6.671e-05,6.464e-05,0,0,1,0.00012,0,5,0.000047,0.00204918032787,1/488,http://exac.broadinstitute.org/variant/8-145742123-G-A,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,4,1,NFS17007000102
741,.,.,HGMD|OMIM|low_frequency,.,.,NFS17007000102,610205;102500,Alagille syndrome 2;Hajdu-Cheney syndrome,"1.$$$mimNumber,610205###prefix,####preferredTitle,ALAGILLE SYNDROME 2; ALGS2###inheritance,Autosomal dominant ###headAndNeckFace,Pointed chin ;###headAndNeckFace,Broad forehead ###headAndNeckEyes,Posterior embryotoxon ###headAndNeckNose,Long nose ;###headAndNeckNose,Bulbous tip ###cardiovascularHeart,Atrial septal defect ;###cardiovascularHeart,Pulmonic stenosis ;###cardiovascularHeart,Tetrology of Fallot ###cardiovascularVascular,Hypertension ###abdomenLiver,Cholestatic liver disease ###genitourinaryKidneys,Small kidneys ;###genitourinaryKidneys,Cystic kidneys ;###genitourinaryKidneys,Renal tubular acidosis ;###genitourinaryKidneys,Renal insufficiency ;###genitourinaryKidneys,Proteinuria ;###genitourinaryKidneys,Hematuria ###miscellaneous,Variable phenotype ###molecularBasis,Caused by mutation in the homology of the Drosophila Notch 2 gene (NOTCH2, ) 2.$$$mimNumber,102500###prefix,####preferredTitle,HAJDU-CHENEY SYNDROME; HJCYS###inheritance,Autosomal dominant ###growthHeight,Short stature ###growthOther,Failure to thrive ###headAndNeckHead,Bathrocephaly ###headAndNeckFace,Coarse facies ;###headAndNeckFace,Long philtrum ;###headAndNeckFace,Full cheeks ;###headAndNeckFace,Micrognathia ###headAndNeckEars,Low-set ears ;###headAndNeckEars,Hearing loss, conductive ;###headAndNeckEars,Prominent ear lobes ###headAndNeckEyes,Downslanting palpebral fissures ;###headAndNeckEyes,Epicanthal folds ;###headAndNeckEyes,Telecanthus ;###headAndNeckEyes,Synophrys ;###headAndNeckEyes,Thick eyebrows ;###headAndNeckEyes,Long eyelashes ###headAndNeckNose,Broad nose ;###headAndNeckNose,Anteverted nares ###headAndNeckMouth,High-arched palate ###headAndNeckTeeth,Early tooth loss ;###headAndNeckTeeth,Malocclusion ###headAndNeckNeck,Short neck ###cardiovascularHeart,Congenital heart disease (variable) ;###cardiovascularHeart,Septal defects ###cardiovascularVascular,Patent ductus arteriosus ###abdomenGastrointestinal,Intestinal malrotation (less common) ###genitourinaryExternalGenitaliaMale,Hypospadias ;###genitourinaryExternalGenitaliaMale,Inguinal hernia ###genitourinaryInternalGenitaliaMale,Cryptorchidism ###genitourinaryKidneys,Renal cysts ###skeletal,Osteopenia ;###skeletal,Osteoporosis ;###skeletal,Pathologic fractures ;###skeletal,Joint laxity ###skeletalSkull,Bathrocephaly ;###skeletalSkull,Wormian bones ;###skeletalSkull,Failure of suture ossification ;###skeletalSkull,Thickened skull vault ;###skeletalSkull,Absent frontal sinus ;###skeletalSkull,Elongated sella turcica ;###skeletalSkull,Progressive basilar impression ;###skeletalSkull,Small mandible ###skeletalSpine,Narrow disc space ;###skeletalSpine,Biconcave vertebrae ;###skeletalSpine,Tall lumbar vertebral bodies ;###skeletalSpine,Kyphoscoliosis ;###skeletalSpine,Cervical instability ;###skeletalSpine,Vertebral collapse ###skeletalLimbs,Joint laxity ;###skeletalLimbs,Genu valgum ;###skeletalLimbs,Dislocation of radial head ;###skeletalLimbs,Long, bowed fibulae ;###skeletalLimbs,Serpentine fibulae ###skeletalHands,Pseudoclubbing ;###skeletalHands,Short distal digits ;###skeletalHands,Acroosteolysis ;###skeletalHands,Crowded carpal bones ###skeletalFeet,Short distal digits ;###skeletalFeet,Acroosteolysis ###skinNailsHairSkin,Hirsutism ###skinNailsHairNails,Short nails ;###skinNailsHairNails,Curved nails ###skinNailsHairHair,Synophrys ;###skinNailsHairHair,Thick eyebrows ;###skinNailsHairHair,Long eyelashes ;###skinNailsHairHair,Thick, straight hair ###neurologicCentralNervousSystem,Hydrocephalus ;###neurologicCentralNervousSystem,Normal intelligence ###molecularBasis,Caused by mutation in the homolog of the Drosophila Notch 2 gene (NOTCH2, )",https://www.omim.org/entry/610205;https://www.omim.org/entry/102500,.,Autosomal dominant,Het,1,120497840,A,T,.,.,PASS,0/1:34:56,60.71,"Tt,,TtTtt.t,..ttT,tt,.,,.tttTt.TTT.t.,,tTttTttT.",missense_variant;missense_variant,NOTCH2,4853,.,NM_024408.3(NOTCH2):c.2042T>A(p.Ile681Asn);NM_001200001.1(NOTCH2):c.2042T>A(p.Ile681Asn),NM_024408.3,exon13(34);exon13(22),NP=>P0;NP=>P0,0.0099,0.002,0,0,0.0003,0.0039,0.0005,0.0068,0,46,0.0053,0,48,0.00040,.,.,http://exac.broadinstitute.org/variant/1-120497840-A-T,3.78,69.2,4,1.0,http://exac.broadinstitute.org/gene/ENSG00000134250,0.40294,.,0.48,T,0.161,B,0.11,B,0.045,U,0.733,N,5.71,13.58,rs74882029,.,.,.,.,NM_024408.3(NOTCH2):c.2042T>A(p.I681N),R,Alagille syndrome,22209762,.,.,.,.,.,134961,https://www.ncbi.nlm.nih.gov/clinvar/variation/134961,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,"apoptotic process (GO:0006915)|atrial septum morphogenesis (GO:0060413)|bone remodeling (GO:0046849)|cell cycle arrest (GO:0007050)|cell fate determination (GO:0001709)|cell growth (GO:0016049)|ciliary body morphogenesis (GO:0061073)|determination of left/right symmetry (GO:0007368)|embryonic limb morphogenesis (GO:0030326)|gene expression (GO:0010467)|hemopoiesis (GO:0030097)|humoral immune response (GO:0006959)|in utero embryonic development (GO:0001701)|inflammatory response to antigenic stimulus (GO:0002437)|interleukin-4 secretion (GO:0072602)|intracellular receptor signaling pathway (GO:0030522)|morphogenesis of an epithelial sheet (GO:0002011)|multicellular organismal development (GO:0007275)|negative regulation of apoptotic process (GO:0043066)|negative regulation of cell proliferation (GO:0008285)|negative regulation of transcription from RNA polymerase II promoter (GO:0000122)|nervous system development (GO:0007399)|Notch receptor processing (GO:0007220)|Notch signaling involved in heart development (GO:0061314)|Notch signaling pathway (GO:0007219)|organ morphogenesis (GO:0009887)|placenta blood vessel development (GO:0060674)|positive regulation of apoptotic process (GO:0043065)|positive regulation of BMP signaling pathway (GO:0030513)|positive regulation of cell proliferation (GO:0008284)|positive regulation of Ras protein signal transduction (GO:0046579)|pulmonary valve morphogenesis (GO:0003184)|regulation of transcription, DNA-templated (GO:0006355)|stem cell maintenance (GO:0019827)|transcription initiation from RNA polymerase II promoter (GO:0006367)",cell surface (GO:0009986)|cilium (GO:0005929)|endoplasmic reticulum membrane (GO:0005789)|extracellular region (GO:0005576)|Golgi membrane (GO:0000139)|integral component of plasma membrane (GO:0005887)|membrane (GO:0016020)|nucleoplasm (GO:0005654)|nucleus (GO:0005634)|plasma membrane (GO:0005886)|receptor complex (GO:0043235),calcium ion binding (GO:0005509)|ligand-activated RNA polymerase II transcription factor binding transcription factor activity (GO:0038049)|receptor activity (GO:0004872),.,.,.,.,71,10,NFS17007000102
745,.,.,HGMD|OMIM,.,.,NFS17007000102,101800;160980;255960;610489,"Acrodysostosis 1, with or without hormone resistance;Adrenocortical tumor, somatic (3);Carney complex, type 1;Myxoma, intracardiac;Pigmented nodular adrenocortical disease, primary, 1","1.$$$mimNumber,101800###prefix,####preferredTitle,ACRODYSOSTOSIS 1 WITH OR WITHOUT HORMONE RESISTANCE; ACRDYS1###inheritance,Autosomal dominant ###growthHeight,Short stature ;###growthHeight,Brachymelic dwarfism (upper limbs greater than lower limbs) ###growthOther,Growth retardation, mild to moderate, prenatal onset ###headAndNeckHead,Brachycephaly ###headAndNeckFace,Hypoplastic maxilla ;###headAndNeckFace,Prognathism ###headAndNeckEars,Hearing loss ###headAndNeckEyes,Epicanthal folds ;###headAndNeckEyes,Hypertelorism ;###headAndNeckEyes,Optic atrophy ;###headAndNeckEyes,Strabismus ;###headAndNeckEyes,Blue eyes (Japanese patients) ###headAndNeckNose,Low nasal bridge ;###headAndNeckNose,Broad, upturned nose ;###headAndNeckNose,Dimpled nasal tip ###headAndNeckTeeth,Malocclusion ;###headAndNeckTeeth,Delayed tooth eruption ;###headAndNeckTeeth,Hypodontia ###genitourinaryInternalGenitaliaMale,Cryptorchidism ###skeletal,Advanced bone age ;###skeletal,Epiphyseal stippling in neonates (lumbosacral and cervical bodies, carpus, tarsus, proximal humerus, terminal phalanges, knees, hips) ###skeletalSkull,Calvarial hyperostosis ;###skeletalSkull,Hypoplastic maxilla ###skeletalSpine,Spinal canal stenosis ;###skeletalSpine,Scoliosis ;###skeletalSpine,Narrow interpediculate distances ;###skeletalSpine,Small vertebrae ###skeletalLimbs,Radial head dislocation ###skeletalHands,Short, broad hands ;###skeletalHands,Short metacarpals ;###skeletalHands,Short phalanges ;###skeletalHands,Cone-shaped epiphyses ###skeletalFeet,Large halluces ;###skeletalFeet,Short metatarsals ###skinNailsHairSkin,Dorsal hand wrinkling ;###skinNailsHairSkin,Pigmented nevi ###neurologicCentralNervousSystem,Mental retardation (IQ 24-85) (variable) ;###neurologicCentralNervousSystem,Hydrocephalus ###endocrineFeatures,Multiple hormone resistance ;###endocrineFeatures,Irregular menses ;###endocrineFeatures,Hypogonadism ###laboratoryAbnormalities,Increased serum parathyroid hormone ;###laboratoryAbnormalities,Low or normal serum calcium ;###laboratoryAbnormalities,Normal or increased serum phosphate ;###laboratoryAbnormalities,Increased urinary cAMP excretion ;###laboratoryAbnormalities,Increased serum thyrotropin ;###laboratoryAbnormalities,Increased serum calcitonin ###miscellaneous,Epiphyseal stippling is gone by 8 months of age ;###miscellaneous,Majority of cases are sporadic ;###miscellaneous,Associated with advanced paternal age ;###miscellaneous,Not all patients have facial dysmorphism ###molecularBasis,Caused by mutation in the cAMP-dependent regulatory subunit 1 of protein kinase A gene (PRKAR1A, ) 2.$$$mimNumber,160980###prefix,####preferredTitle,CARNEY COMPLEX, TYPE 1; CNC1###inheritance,Autosomal dominant ###headAndNeckEyes,Conjunctival and scleral pigmentation ;###headAndNeckEyes,Eyelid myxoma ###cardiovascularHeart,Atrial myxoma ;###cardiovascularHeart,Ventricular myxoma ;###cardiovascularHeart,Congestive heart failure ###skinNailsHairSkin,Profuse pigmented skin lesions ;###skinNailsHairSkin,Nevi ;###skinNailsHairSkin,Ephelides ;###skinNailsHairSkin,Centrofacial/mucosal lentigines ;###skinNailsHairSkin,Blue nevi ###skinNailsHairHair,Hirsuitism ;###skinNailsHairHair,Red Hair ###endocrineFeatures,Pigmented micronodular adrenal dysplasia ;###endocrineFeatures,Cushing disease ;###endocrineFeatures,Acromegaly ;###endocrineFeatures,Thyroid follicular hyperplasia ###neoplasia,Myxoid subcutaneous tumors ;###neoplasia,Primary adrenocortical nodular hyperplasia ;###neoplasia,Testicular Sertoli cell tumor, calcified ;###neoplasia,Pituitary adenoma ;###neoplasia,Mammary ductal fibroadenoma ;###neoplasia,Schwannoma ;###neoplasia,Psammomatous melanotic schwannomas ;###neoplasia,Thyroid carcinoma ;###neoplasia,Pheochromocytoma ###miscellaneous,Genetic heterogeneity (see CNC2, ###molecularBasis,Caused by mutation in the cAMP-dependent protein kinase, regulatory, type I, alpha gene (PRKAR1A, ) 3.$$$mimNumber,255960###prefix,####preferredTitle,MYXOMA, INTRACARDIAC###inheritance,Autosomal dominant ###cardiovascularHeart,Left atrial myxoma ;###cardiovascularHeart,Right atrial myxoma ;###cardiovascularHeart,Pulmonic valve myxoma ;###cardiovascularHeart,Bacterial endocarditis susceptible###molecularBasis,Caused by mutation in the protein kinase, cAMP-dependent, regulatory, type I, alpha gene (PRKAR1A, ) 4.$$$mimNumber,610489###prefix,####preferredTitle,PIGMENTED NODULAR ADRENOCORTICAL DISEASE, PRIMARY, 1; PPNAD1###inheritance,Autosomal dominant ###growthWeight,Truncal obesity ###headAndNeckFace,Round face ###cardiovascularVascular,Hypertension ###skeletal,Decreased bone mineral density ;###skeletal,Osteoporosis ###skeletalSpine,Kyphosis ###skinNailsHairSkin,Thin skin ;###skinNailsHairSkin,Striae ;###skinNailsHairSkin,Easy bruising ###neurologicCentralNervousSystem,Cognitive decline ###neurologicBehavioralPsychiatricManifestations,Mood changes ;###neurologicBehavioralPsychiatricManifestations,Depression ;###neurologicBehavioralPsychiatricManifestations,Agitation ;###neurologicBehavioralPsychiatricManifestations,Anxiety ;###neurologicBehavioralPsychiatricManifestations,Psychosis ###endocrineFeatures,Cushing syndrome ;###endocrineFeatures,Pigmented micronodular adrenocortical disease ;###endocrineFeatures,ACTH-independent hypercortisolemia ;###endocrineFeatures,Adrenal glands may be normal, atrophic, or slightly enlarged ###laboratoryAbnormalities,Increased serum cortisol ;###laboratoryAbnormalities,Paradoxical increased cortisol secretion on dexamethasone suppression test ;###laboratoryAbnormalities,Decreased serum ACTH ###miscellaneous,Onset in childhood or young adulthood ;###miscellaneous,Manifestations of Cushing syndrome may be mild ;###miscellaneous,Genetic heterogeneity, see PPNAD2 ();###miscellaneous,Usually a manifestation of the Carney complex (CNC1, )###molecularBasis,Caused by mutation in the cAMP-dependent protein kinase, regulatory, type I, alpha gene (PRKAR1A, )",https://www.omim.org/entry/101800;https://www.omim.org/entry/160980;https://www.omim.org/entry/255960;https://www.omim.org/entry/610489,.,Autosomal dominant,Het,17,66537003,G,A,.,.,strand fail,0/1:7:23,30.43,"..,.,..a.a,.aAaa,,..^].",intron_variant,PRKAR1A,5573,.,NM_001276290.1(PRKAR1A):c.974-10222G>A,NM_002734.4,intron9(9),.,0.03,0.006,0,0,0.0020,0.0263,0.0018,0.0308,1,207,0.046,1,215,0.0040,0.0532786885246,26/488,http://exac.broadinstitute.org/variant/17-66537003-G-A,3.51,20.4,0,1.0,http://exac.broadinstitute.org/gene/ENSG00000108946,.,.,.,.,.,.,.,.,.,.,.,.,.,.,rs2286559,.,.,.,.,.,.,.,.,.,.,.,.,"NM_017565.3(FAM20A):c.1207G>A(p.D403N),DM,Enamel-renal syndrome,24196488",.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,activation of phospholipase C activity (GO:0007202)|activation of protein kinase A activity (GO:0034199)|blood coagulation (GO:0007596)|cardiac muscle cell proliferation (GO:0060038)|cellular response to glucagon stimulus (GO:0071377)|energy reserve metabolic process (GO:0006112)|epidermal growth factor receptor signaling pathway (GO:0007173)|female meiotic division (GO:0007143)|fibroblast growth factor receptor signaling pathway (GO:0008543)|innate immune response (GO:0045087)|intracellular signal transduction (GO:0035556)|mesoderm formation (GO:0001707)|negative regulation of cAMP-dependent protein kinase activity (GO:2000480)|negative regulation of meiosis (GO:0045835)|neurotrophin TRK receptor signaling pathway (GO:0048011)|regulation of insulin secretion (GO:0050796)|regulation of transcription from RNA polymerase II promoter (GO:0006357)|sarcomere organization (GO:0045214)|signal transduction (GO:0007165)|small molecule metabolic process (GO:0044281)|transmembrane transport (GO:0055085)|water transport (GO:0006833),AMP-activated protein kinase complex (GO:0031588)|cAMP-dependent protein kinase complex (GO:0005952)|cytosol (GO:0005829)|membrane (GO:0016020)|neuromuscular junction (GO:0031594)|plasma membrane (GO:0005886)|protein complex (GO:0043234),cAMP binding (GO:0030552)|cAMP-dependent protein kinase inhibitor activity (GO:0004862)|cAMP-dependent protein kinase regulator activity (GO:0008603)|protein kinase A catalytic subunit binding (GO:0034236)|ubiquitin protein ligase binding (GO:0031625),.,.,.,.,30,3,NFS17007000102
760,.,.,OMIM|low_frequency,Name=GCcontent,.,NFS17007000102,615007;616592;131440;228550;601812,"Basal ganglia calcification, idiopathic, 4;Kosaki overgrowth syndrome;Myeloproliferative disorder with eosinophilia;Myofibromatosis, infantile, 1;Premature aging syndrome, Penttinen type","1.$$$mimNumber,615007###prefix,####preferredTitle,BASAL GANGLIA CALCIFICATION, IDIOPATHIC, 4; IBGC4###inheritance,Autosomal dominant ###headAndNeckEyes,Nystagmus (rare) ###neurologicCentralNervousSystem,Basal ganglia calcifications ;###neurologicCentralNervousSystem,Parkinsonism (in some) ;###neurologicCentralNervousSystem,Impaired executive function (in some patients) ;###neurologicCentralNervousSystem,Dementia (in some patients) ;###neurologicCentralNervousSystem,Migraine (in some patients) ;###neurologicCentralNervousSystem,Subcortical atrophy (in some patients) ;###neurologicCentralNervousSystem,Subcortical and periventricular white matter abnormalities seen on MRI (in some patients) ###neurologicBehavioralPsychiatricManifestations,Depression (in some patients) ###miscellaneous,One large French family and 1 patient with sporadic occurrence have been reported (last curated January 2013) ;###miscellaneous,Most patients are asymptomatic ;###miscellaneous,Variable age of onset of symptoms ###molecularBasis,Caused by mutation in the platelet-derived growth factor receptor, beta polypeptide gene (PDGFRB, ) 2.$$$mimNumber,616592###prefix,####preferredTitle,KOSAKI OVERGROWTH SYNDROME; KOGS###inheritance,Autosomal dominant ###growthHeight,Tall stature ###headAndNeckFace,Prominent forehead ;###headAndNeckFace,Prominent supraorbital ridge ;###headAndNeckFace,Pointed chin ###headAndNeckEyes,Proptosis ;###headAndNeckEyes,Ptosis ;###headAndNeckEyes,Downslanting palpebral fissures ###headAndNeckNose,Wide nasal bridge ###headAndNeckMouth,Thin upper lip ###skeletal,Overgrowth ###skeletalSkull,Prominent supraorbital ridge ;###skeletalSkull,Protrusion of posterior fossa ###skeletalSpine,Thoracolumbar scoliosis ###skeletalLimbs,Long lower segment ###skeletalHands,Long hands ###skeletalFeet,Long feet ###skinNailsHairSkin,Hyperelastic skin ;###skinNailsHairSkin,Thin skin ;###skinNailsHairSkin,Fragile skin ###muscleSoftTissue,Myofibroma (in 1 patient) ###neurologicCentralNervousSystem,Progressive neurologic deterioration ;###neurologicCentralNervousSystem,Worsening mental retardation (in 1 patient) ;###neurologicCentralNervousSystem,Periventricular white matter lesions ###neurologicBehavioralPsychiatricManifestations,Depression (in 1 patient) ;###neurologicBehavioralPsychiatricManifestations,Anxiety (in 1 patient) ;###neurologicBehavioralPsychiatricManifestations,Schizophrenic symptoms (in 1 patient) ###miscellaneous,Based on report of 2 unrelated Japanese girls (last curated October 2015) ###molecularBasis,Caused by mutation in the platelet-derived growth factor receptor, beta polypeptide gene (PDGFRB, ) 3.$$$mimNumber,228550###prefix,####preferredTitle,MYOFIBROMATOSIS, INFANTILE, 1; IMF1###inheritance,Autosomal dominant ###muscleSoftTissue,Myofibromatosis affecting skin, muscle, bone, and viscera ;###muscleSoftTissue,Small, firm, rubbery, flesh-colored nodules most commonly found on the head, neck, and trunk ;###muscleSoftTissue,Benign soft tissue developmental anomalies ;###muscleSoftTissue,Dermal or subcutaneous infiltrate of spindle-shaped cells arranged in a whorled pattern seen on histology ###miscellaneous,Onset at birth or in early childhood ;###miscellaneous,Tumors may show spontaneous regression ;###miscellaneous,Visceral multicentric involvement has a poorer prognosis than solitary lesions limited to the skin ;###miscellaneous,Solitary disease is more common in males ###molecularBasis,Caused by mutation in the platelet-derived growth factor receptor, beta, gene (PDGFRB, ) 4.$$$mimNumber,601812###prefix,####preferredTitle,PREMATURE AGING SYNDROME, PENTTINEN TYPE; PENTT###inheritance,Autosomal dominant ###growthHeight,Normal or increased ###headAndNeckFace,Midface hypoplasia ###headAndNeckEars,Sensorineural hearing loss (rare) ###headAndNeckEyes,Proptosis ;###headAndNeckEyes,Recurrent pterygia (in some patients) ###headAndNeckNose,Narrow nose ;###headAndNeckNose,Convex nasal bridge ###headAndNeckMouth,Thin lips ###headAndNeckTeeth,Delayed tooth eruption ###skeletal,Delayed bone maturation ;###skeletal,Osteopenia ###skeletalSkull,Delayed closure of fontanels ;###skeletalSkull,Thin calvarium ;###skeletalSkull,Wormian bones (in some patients) ;###skeletalSkull,Zygomatic arch hypoplasia ;###skeletalSkull,Maxillary hypoplasia ;###skeletalSkull,Mandibular hypoplasia ###skeletalSpine,Scoliosis (in some patients) ###skeletalLimbs,Contractures of joints ;###skeletalLimbs,Thin long bones ###skeletalHands,Acroosteolysis ;###skeletalHands,Brachydactyly ;###skeletalHands,Contractures of fingers ###skeletalFeet,Acroosteolysis ;###skeletalFeet,Brachydactyly (in some patients) ;###skeletalFeet,Contractures of toes ###skinNailsHairSkin,Progressive cutaneous atrophy ;###skinNailsHairSkin,Thin translucent skin with prominent venous patterning ;###skinNailsHairSkin,Hypertrophic keloid-like lesions ;###skinNailsHairSkin,Skin retraction ###skinNailsHairSkinHistology,Epidermal atrophy ;###skinNailsHairSkinHistology,Hyperkeratosis ;###skinNailsHairSkinHistology,Dermal fibrosis ;###skinNailsHairSkinHistology,Nonspecific mononuclear inflammation ;###skinNailsHairSkinHistology,Lack of elastic fibers in reticular dermis ###skinNailsHairHair,Sparse hair ###muscleSoftTissue,Lipoatrophy ###neurologicCentralNervousSystem,Normal intellect ###molecularBasis,Caused by mutation in the platelet-derived growth factor receptor, beta polypeptide gene (PDGFRB, )",https://www.omim.org/entry/615007;https://www.omim.org/entry/616592;https://www.omim.org/entry/131440;https://www.omim.org/entry/228550;https://www.omim.org/entry/601812,.,Autosomal dominant,Het,5,149509395,G,A,.,.,PASS,0/1:78:148,52.7,"A....AA..A..AAA.AAA.a...AAA..A..A.AAA.......A..AAA..AAAAAAA..,.aaAAa.,,Aa.A$AA..AAAAA,aAA,..AAA.A.AA.a,A.,A.A..AAA.aA.A.A..A.^].",missense_variant,PDGFRB,5159,.,NM_002609.3(PDGFRB):c.1504C>T(p.Arg502Trp),NM_002609.3,exon10(23),P+=>NP,.,0.0006,12,0.00092,0.0011,5.799e-05,0.0009,0,0,0,0,2,146,0.0012,.,.,http://exac.broadinstitute.org/variant/5-149509395-G-A,2.13,41.0,5,1.0,http://exac.broadinstitute.org/gene/ENSG00000113721,0.61624,0.001279,0.01,D,0.987,D,0.462,P,0.153,N,0.988,N,4.05,17.36,rs142992960,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,adrenal gland development (GO:0030325)|aorta morphogenesis (GO:0035909)|cardiac myofibril assembly (GO:0055003)|cell chemotaxis (GO:0060326)|cell migration (GO:0016477)|cell migration involved in coronary angiogenesis (GO:0060981)|cell migration involved in vasculogenesis (GO:0035441)|cellular response to platelet-derived growth factor stimulus (GO:0036120)|epidermal growth factor receptor signaling pathway (GO:0007173)|Fc-epsilon receptor signaling pathway (GO:0038095)|fibroblast growth factor receptor signaling pathway (GO:0008543)|G-protein coupled receptor signaling pathway (GO:0007186)|glycosaminoglycan biosynthetic process (GO:0006024)|in utero embryonic development (GO:0001701)|innate immune response (GO:0045087)|inner ear development (GO:0048839)|metanephric comma-shaped body morphogenesis (GO:0072278)|metanephric glomerular capillary formation (GO:0072277)|metanephric glomerular mesangial cell proliferation involved in metanephros development (GO:0072262)|metanephric mesenchymal cell migration (GO:0035789)|metanephric mesenchyme development (GO:0072075)|metanephric S-shaped body morphogenesis (GO:0072284)|negative regulation of apoptotic process (GO:0043066)|neurotrophin TRK receptor signaling pathway (GO:0048011)|peptidyl-tyrosine phosphorylation (GO:0018108)|phosphatidylinositol metabolic process (GO:0046488)|phosphatidylinositol-mediated signaling (GO:0048015)|platelet-derived growth factor receptor signaling pathway (GO:0048008)|platelet-derived growth factor receptor-beta signaling pathway (GO:0035791)|positive regulation of calcium ion import (GO:0090280)|positive regulation of cell migration (GO:0030335)|positive regulation of cell proliferation (GO:0008284)|positive regulation of cell proliferation by VEGF-activated platelet derived growth factor receptor signaling pathway (GO:0038091)|positive regulation of chemotaxis (GO:0050921)|positive regulation of collagen biosynthetic process (GO:0032967)|positive regulation of DNA biosynthetic process (GO:2000573)|positive regulation of ERK1 and ERK2 cascade (GO:0070374)|positive regulation of MAP kinase activity (GO:0043406)|positive regulation of metanephric mesenchymal cell migration by platelet-derived growth factor receptor-beta signaling pathway (GO:0035793)|positive regulation of mitosis (GO:0045840)|positive regulation of phosphatidylinositol 3-kinase activity (GO:0043552)|positive regulation of phosphatidylinositol 3-kinase signaling (GO:0014068)|positive regulation of phospholipase C activity (GO:0010863)|positive regulation of phosphoprotein phosphatase activity (GO:0032516)|positive regulation of reactive oxygen species metabolic process (GO:2000379)|positive regulation of smooth muscle cell migration (GO:0014911)|positive regulation of smooth muscle cell proliferation (GO:0048661)|protein autophosphorylation (GO:0046777)|regulation of actin cytoskeleton organization (GO:0032956)|regulation of peptidyl-tyrosine phosphorylation (GO:0050730)|response to estradiol (GO:0032355)|response to fluid shear stress (GO:0034405)|response to hydrogen peroxide (GO:0042542)|response to hyperoxia (GO:0055093)|response to retinoic acid (GO:0032526)|response to toxic substance (GO:0009636)|retina vasculature development in camera-type eye (GO:0061298)|signal transduction (GO:0007165)|skeletal system morphogenesis (GO:0048705)|smooth muscle cell chemotaxis (GO:0071670)|smooth muscle tissue development (GO:0048745)|tissue homeostasis (GO:0001894)|transforming growth factor beta receptor signaling pathway (GO:0007179)|wound healing (GO:0042060),apical plasma membrane (GO:0016324)|cell surface (GO:0009986)|cytoplasm (GO:0005737)|cytoplasmic vesicle (GO:0031410)|extracellular vesicular exosome (GO:0070062)|focal adhesion (GO:0005925)|integral component of membrane (GO:0016021)|intrinsic component of plasma membrane (GO:0031226)|lysosome (GO:0005764)|membrane (GO:0016020)|nucleus (GO:0005634)|plasma membrane (GO:0005886),ATP binding (GO:0005524)|platelet activating factor receptor activity (GO:0004992)|platelet-derived growth factor beta-receptor activity (GO:0005019)|platelet-derived growth factor binding (GO:0048407)|platelet-derived growth factor receptor binding (GO:0005161)|platelet-derived growth factor-activated receptor activity (GO:0005017)|protein kinase binding (GO:0019901)|protein tyrosine kinase activity (GO:0004713)|receptor binding (GO:0005102)|vascular endothelial growth factor binding (GO:0038085),.,.,.,.,31,4,NFS17007000102
763,.,.,HGMD|OMIM,.,.,NFS17007000102,209880;142623;155240;171400;162300;171300,"Central hypoventilation syndrome, congenital;Hirschsprung disease, susceptibility to, 1;Medullary thyroid carcinoma;Multiple endocrine neoplasia IIA;Multiple endocrine neoplasia IIB;Pheochromocytoma","1.$$$mimNumber,209880###prefix,####preferredTitle,CENTRAL HYPOVENTILATION SYNDROME, CONGENITAL; CCHS###inheritance,Autosomal dominant ###headAndNeckEyes,Diminished pupillary light responses ###respiratory,Alveolar hypoventilation ;###respiratory,Shallow breathing (decreased tidal volume) ;###respiratory,Normal respiratory rate ;###respiratory,Periods of apnea ;###respiratory,Abnormal respiration due to defect in autonomic function ;###respiratory,Decreased sensitivity to hypercapnia and hypoxemia ###abdomenGastrointestinal,Poor feeding ;###abdomenGastrointestinal,Constipation ;###abdomenGastrointestinal,Hirschsprung disease (16%) ###skinNailsHairSkin,Increased sweating ###neurologicCentralNervousSystem,Dysfunction of the autonomic nervous system ###metabolicFeatures,Poor temperature regulation ;###metabolicFeatures,Decreased basal body temperature ###neoplasia,Tumors of the sympathetic nervous system (5 to 10%) ;###neoplasia,Neuroblastoma ;###neoplasia,Ganglioneuroma ;###neoplasia,Ganglioneuroblastoma ###laboratoryAbnormalities,Chronic hypoxemia ;###laboratoryAbnormalities,Chronic hypercapnia ###miscellaneous,Onset usually at birth ;###miscellaneous,Worsening of symptoms during sleep ;###miscellaneous,Some patients have later onset of the disorder as young adults ;###miscellaneous,Patients often have other clinical symptoms resulting from dysfunction of the autonomic nervous system ;###miscellaneous,Hypoventilation occurs in the absence of primary neuromuscular, lung, or cardiac disease, or an identifiable brainstem lesion ;###miscellaneous,Most cases are caused by mutation in the PHOX2B gene ###molecularBasis,Caused by mutation in the paired-like homeobox 2B gene (PHOX2B, );###molecularBasis,Caused by mutation in the rearranged during transfection protooncogene (RET, );###molecularBasis,Caused by mutation in the endothelin 3 (EDN3, );###molecularBasis,Caused by mutation in the glial cell line-derived neurotrophic factor gene (GDNF, );###molecularBasis,Caused by mutation in the brain-derived neurotrophic factor gene (BDNF, );###molecularBasis,Caused by mutation in the homolog of the Drosophila achaete-scute complex, 1 gene (ASCL1, ) 2.$$$mimNumber,142623###prefix,####preferredTitle,HIRSCHSPRUNG DISEASE, SUSCEPTIBILITY TO, 1; HSCR1###inheritance,Autosomal dominant ###abdomenGastrointestinal,Failure to pass meconium in first 48 hours of life ;###abdomenGastrointestinal,Constipation ;###abdomenGastrointestinal,Abdominal distention ;###abdomenGastrointestinal,Vomiting ;###abdomenGastrointestinal,Enterocolitis ;###abdomenGastrointestinal,Barium enema shows transition zone between aganglionic contracted segment and dilated proximal bowel ###laboratoryAbnormalities,Absent enteric ganglia beginning at the rectum and extends proximally by varying degrees ;###laboratoryAbnormalities,Acetylcholinesterase staining reveals nerve trunk hypertrophy ###miscellaneous,Male predominance of 3:1 to 5:1 ;###miscellaneous,Familial (10%) and isolated cases ###molecularBasis,Caused by mutation in the RET protooncogene (RET, );###molecularBasis,Caused by mutation in the endothelin receptor type B gene (EDNRB, );###molecularBasis,Caused by mutation in the endothelin 3 gene (EDN3, );###molecularBasis,Caused by mutation in the glial cell line-derived neurotrophic factor gene (GDNF, ) 3.$$$mimNumber,171400###prefix,####preferredTitle,MULTIPLE ENDOCRINE NEOPLASIA, TYPE IIA; MEN2A###inheritance,Autosomal dominant ###abdomenGastrointestinal,Hirschsprung disease ###skinNailsHairSkin,Cutaneous lichen amyloidosis ###endocrineFeatures,Cushing syndrome ;###endocrineFeatures,Hypertension ;###endocrineFeatures,C-cell hyperplasia ;###endocrineFeatures,Hyperparathyroidism ###neoplasia,Pheochromocytoma ;###neoplasia,Medullary thyroid carcinoma ;###neoplasia,Parathyroid adenoma ###laboratoryAbnormalities,Increased urinary epinephrine ;###laboratoryAbnormalities,Elevated calcitonin ;###laboratoryAbnormalities,Pentagastrin stimulation test ###molecularBasis,Caused by mutations in the RET protoncogene (RET, ) 4.$$$mimNumber,162300###prefix,####preferredTitle,MULTIPLE ENDOCRINE NEOPLASIA, TYPE IIB; MEN2B###inheritance,Autosomal dominant ###growthHeight,Marfanoid body habitus ###growthOther,Failure to thrive in infancy ###headAndNeckFace,Coarse-appearing facies ###headAndNeckEyes,Pedunculated nodules on eyelid margins ;###headAndNeckEyes,Eyelid and corneal neuromas ;###headAndNeckEyes,Medullated corneal nerve fibers ;###headAndNeckEyes,Thickened, anteverted eyelid ;###headAndNeckEyes,Large, prominent eyebrow ###headAndNeckMouth,Neuromas of lips and tongue ;###headAndNeckMouth,Thick lips ;###headAndNeckMouth,High arched palate ###headAndNeckNeck,Nodular goiter ###chestRibsSternumClaviclesAndScapulae,Pectus excavatum ###abdomenGastrointestinal,Megacolon ;###abdomenGastrointestinal,Colonic diverticulosis ;###abdomenGastrointestinal,Constipation ;###abdomenGastrointestinal,Diarrhea ;###abdomenGastrointestinal,Ganglioneuroma ###skeletalSpine,Scoliosis ;###skeletalSpine,Kyphosis ;###skeletalSpine,Lordosis ###skeletalLimbs,Joint laxity ;###skeletalLimbs,Slipped capital femoral epiphyses ###skeletalFeet,Pes cavus ###skinNailsHairSkin,Flushing attacks ###muscleSoftTissue,Myopathy ###neurologicCentralNervousSystem,Hypotonia ;###neurologicCentralNervousSystem,Developmental delay ###endocrineFeatures,Parathyroid hyperplasia ###neoplasia,Ganglioneuroma ;###neoplasia,Pheochromocytoma ;###neoplasia,Medullary thyroid carcinoma ;###neoplasia,Parathyroid disease rare ###laboratoryAbnormalities,Pentagastrin stimulation test ;###laboratoryAbnormalities,Elevated calcitonin ;###laboratoryAbnormalities,Increased urinary epinephrine ###miscellaneous,Medullary thyroid cancer is aggressive and can occur in childhood ;###miscellaneous,Fifty percent of cases are sporadic ###molecularBasis,Caused by mutation in the RET protooncogene (RET, ) ",https://www.omim.org/entry/209880;https://www.omim.org/entry/142623;https://www.omim.org/entry/155240;https://www.omim.org/entry/171400;https://www.omim.org/entry/162300;https://www.omim.org/entry/171300,.,Autosomal dominant,Het,10,43606856,G,A,.,.,PASS,0/1:45:95,47.37,".$,$aaAa,,.a.a,,aa,A,,,.a.A.aaA...a,,A.a,a,aAA...,.AAa,Aa,,A.,,.a.aA,aA,,,,A.,,aAa..aaAa",missense_variant;missense_variant,RET,5979,.,NM_020630.4(RET):c.1465G>A(p.Asp489Asn);NM_020975.4(RET):c.1465G>A(p.Asp489Asn),NM_020975.4,exon7(19);exon7(20),P-=>P0;P-=>P0,0.019,0.0038,2,0.00015,0.0022,0.0282,0.0016,0.0296,2,236,0.027,2,248,0.0021,0.0389344262295,19/488,http://exac.broadinstitute.org/variant/10-43606856-G-A,1.77,34.4,2,1.0,http://exac.broadinstitute.org/gene/ENSG00000165731,0.07184,1.16E-4,0.3,T,0.015,B,0.006,B,0.001,N,1.000,N,2.94,3.631,rs9282834,.,.,.,.,NM_020975.4(RET):c.1465G>A(p.D489N),DP,"Hirschsprung disease, association with",23114404,.,.,.,.,"NM_020975.4(RET):c.1466A>G(p.D489G),DM,Hirschsprung disease,17640327",135190,https://www.ncbi.nlm.nih.gov/clinvar/variation/135190,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,"activation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0006919)|cellular response to retinoic acid (GO:0071300)|embryonic epithelial tube formation (GO:0001838)|enteric nervous system development (GO:0048484)|homophilic cell adhesion (GO:0007156)|innervation (GO:0060384)|lymphocyte migration into lymphoid organs (GO:0097021)|MAPK cascade (GO:0000165)|membrane protein proteolysis (GO:0033619)|neural crest cell migration (GO:0001755)|neuron cell-cell adhesion (GO:0007158)|neuron maturation (GO:0042551)|peptidyl-tyrosine phosphorylation (GO:0018108)|Peyer's patch morphogenesis (GO:0061146)|positive regulation of cell adhesion mediated by integrin (GO:0033630)|positive regulation of cell migration (GO:0030335)|positive regulation of cell size (GO:0045793)|positive regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001241)|positive regulation of metanephric glomerulus development (GO:0072300)|positive regulation of neuron maturation (GO:0014042)|positive regulation of neuron projection development (GO:0010976)|positive regulation of transcription, DNA-templated (GO:0045893)|posterior midgut development (GO:0007497)|protein phosphorylation (GO:0006468)|regulation of axonogenesis (GO:0050770)|regulation of cell adhesion (GO:0030155)|response to drug (GO:0042493)|response to pain (GO:0048265)|retina development in camera-type eye (GO:0060041)|signal transduction (GO:0007165)|transmembrane receptor protein tyrosine kinase signaling pathway (GO:0007169)|ureter maturation (GO:0035799)|ureteric bud development (GO:0001657)",endosome membrane (GO:0010008)|integral component of plasma membrane (GO:0005887)|membrane raft (GO:0045121)|receptor complex (GO:0043235),ATP binding (GO:0005524)|calcium ion binding (GO:0005509)|protein tyrosine kinase activity (GO:0004713)|receptor activity (GO:0004872)|transmembrane receptor protein tyrosine kinase activity (GO:0004714),.,.,.,.,18,2,NFS17007000102
